Chime counsel sells 102K shares after option exercise

Chime Financial’s General Counsel exercised 60,000 options and sold 102,002 shares in pre-planned trades on September 15, 2026.

Rhea-AI Filing Summary

Chime Financial, Inc. (CHYM) reported that General Counsel Adam B. Frankel exercised options for 60,000 shares of Class A common stock on September 15, 2026 at an exercise price of $16.56 per share, with the related option scheduled to expire on August 31, 2033.

On the same date he sold an aggregate of 102,002 shares of Class A common stock in open-market transactions at weighted average prices of $33.2269 and $33.7846 per share, with sale price ranges from $32.760–$33.755 and $33.76–$33.96 per share, pursuant to a Rule 10b5-1 trading plan adopted June 16, 2026. Following the option exercise, he held 213,567 shares subject to that option award, which vests over time beginning August 8, 2024.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider FRANKEL ADAM B

Role General Counsel

Sold 102,002 shs ($3.40M)

Approx. gross sale proceeds $3.40M

Approx. exercise cost $994K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to buy) F5	60,000	$16.56	$994K
Exercise	Class A Common Stock F1	60,000	$16.56	$994K
Sale	Class A Common Stock F2, F3, F1	86,948	$33.2269	$2.89M
Sale	Class A Common Stock F2, F4, F1	15,054	$33.7846	$509K

Holdings After Transaction: Employee Stock Option (Right to buy) — 213,567 contracts (Direct); Class A Common Stock — 364,828 shares (Direct)

Footnotes (5)

1. F1. Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
2. F2. This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, adopted June 16, 2026.
3. F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.760 to $33.755 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.
4. F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.76 to $33.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.
5. F5. 1/4th of the shares subject to the option vested on August 8, 2024 and 1/48th of the shares vest monthly thereafter, subject to the Reporting Person's continued service through each vesting date.

Key Figures

Options exercised: 60,000 shares Option exercise price: $16.56 per share Shares sold (first block): 86,948 shares +5 more

8 metrics

Options exercised 60,000 shares Options for Class A common stock exercised on September 15, 2026

Option exercise price $16.56 per share Exercise price for 60,000 options on September 15, 2026

Shares sold (first block) 86,948 shares Class A common stock sold on September 15, 2026 at weighted average $33.2269

Shares sold (second block) 15,054 shares Class A common stock sold on September 15, 2026 at weighted average $33.7846

Sale price ranges $32.760–$33.755 and $33.76–$33.96 per share Price ranges for the two groups of sales on September 15, 2026

Option shares remaining under award 213,567 shares Shares subject to the option following the reported exercise

Option expiration date August 31, 2033 Expiration date of the option from which 60,000 shares were exercised

Vesting commencement for option/RSUs August 8, 2024 One quarter vested on this date; remaining vest monthly thereafter

Key Terms

Rule 10b5-1 trading plan, restricted stock units ("RSUs"), weighted average price, contingent right to receive one share

4 terms

Rule 10b5-1 trading plan regulatory

"This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, adopted June 16, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

restricted stock units ("RSUs") financial

"Certain of these securities are restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

weighted average price financial

"The reported price in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

contingent right to receive one share financial

"Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did CHYM’s General Counsel report on September 15, 2026?

Adam B. Frankel reported exercising options for 60,000 shares of Class A common stock at $16.56 per share and selling 102,002 shares of Class A common stock in open-market transactions on September 15, 2026.

At what prices were the CHYM shares sold in the September 15, 2026 transactions?

The reported weighted average sale prices were $33.2269 for 86,948 shares and $33.7846 for 15,054 shares. The shares were sold in multiple trades at prices ranging from $32.760–$33.755 and $33.76–$33.96 per share, respectively.

Were the September 15, 2026 CHYM stock sales under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan that was adopted June 16, 2026, indicating the sale instructions were pre-arranged under that plan.

How many options did the CHYM General Counsel exercise and at what price?

He exercised options covering 60,000 shares of Chime Financial Class A common stock at an exercise price of $16.56 per share on September 15, 2026, resulting in the acquisition of 60,000 shares of Class A common stock.

What is the status and vesting schedule of the option and RSUs reported for CHYM?

After the reported transaction, the relevant option shows 213,567 shares subject to it, expiring on August 31, 2033. A related footnote describes restricted stock units, each representing a contingent right to receive one share, vesting over time beginning August 8, 2024.

What role does the reporting person hold at Chime Financial (CHYM)?

The reporting person, Adam B. Frankel, is identified as the company’s General Counsel, and the Form 4 details his option exercise and share sale activity in Chime Financial’s Class A common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 06:20 PM Accepted by SEC EDGAR 09/16/2026 - 06:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FRANKEL ADAM B

(Last) (First) (Middle)

C/O CHIME FINANCIAL, INC.

101 CALIFORNIA STREET, SUITE 500

(Street)

SAN FRANCISCO CALIFORNIA 94111

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Chime Financial, Inc. [ CHYM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/15/2026		M		60,000	A	$16.56	466,830(1)	D
Class A Common Stock	09/15/2026		S(2)		86,948	D	$33.2269(3)	379,882(1)	D
Class A Common Stock	09/15/2026		S(2)		15,054	D	$33.7846(4)	364,828(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to buy)	$16.56	09/15/2026		M			60,000	(5)	08/31/2033	Class A Common Stock	60,000	$16.56	213,567	D

Explanation of Responses:

1. Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

2. This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, adopted June 16, 2026.

3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.760 to $33.755 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.

4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.76 to $33.96 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separated price within the range set forth in this footnote.

5. 1/4th of the shares subject to the option vested on August 8, 2024 and 1/48th of the shares vest monthly thereafter, subject to the Reporting Person's continued service through each vesting date.

Remarks:

	/s/ Theresa Bloom, by power of attorney	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)